Just-Health-TAMSIN

Tamsin Tierney, director, Just Health PR

December 2, 2009
Medical Communications appointment, just health pr, medical communications

Just Health PR has appointed Tamsin Tierney to the newly created role of director.Tamsin was previously at Hill & Knowlton …

Pfizer Europe's YouTube channel

Digital Pharma: Pfizer launches European YouTube channel

December 2, 2009
Medical Communications, Sales and Marketing Pfizer, digi, digital pharma, youtube

Pfizer has set up a YouTube channel to promote its European operations by showcasing some of its people.In one sequence …

Bayer takes Alzheimer’s diagnostic into pivotal trials

December 2, 2009
Research and Development Alz, Bayer, diagnostic

An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …

Adapt or die

December 2, 2009
Manufacturing and Production competition, generics, industry, pa consulting

For years, healthcare has been one of the most profitable sectors in industry. However the world is changing, and fast.Generics …

Oxford BioTherapeutics appoints Dr Jim Cornett, Dr Jon Terrett and Dr Mike Gresser

December 2, 2009
Research and Development Oxford Biotherapeutics, appointment, research and development

Oxford BioTherapeutics has expanded its US operations, recruiting a number of senior industry leaders.Dr Jim Cornett will head up operations …

New deal supports French pharma and biotech

December 1, 2009
Research and Development, Sales and Marketing France, biotech

 The French government has agreed a new deal with industry leaders to help the country’s pharma and biotech industries.President Sarkozy …

PPD buys BioDuro to get bigger in China

December 1, 2009
Research and Development CRO, China, em

Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …

Building value – is the pipeline all that matters?

December 1, 2009
Research and Development Les Rose, biotech, venture capital

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …

Incyte’s Novartis cancer drug deal could be worth $1bn

December 1, 2009
Research and Development Incyte, Novartis

Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …

Shire

Shire files for Gaucher drug in Europe

December 1, 2009
Sales and Marketing Cerezyme, Gaucher, Shire

 Shire has followed up its marketing applications for Gaucher disease treatment velaglucerase alfa in the US and Canada with a …

UK faces north/south divide on cancer

December 1, 2009
Sales and Marketing Cancer, NHS

There is a marked north/south divide when it comes to cancer patients’ chances of recovery, according to new statistics. The …

Drugmakers look to property portfolios for cost-savings

December 1, 2009
Manufacturing and Production CB Richard Ellis, property

Increasing numbers of pharmaceutical companies are cutting costs by selling properties and leasing them back off the new owners, according …

Manufacturing news in brief

December 1, 2009
Manufacturing and Production Aurobindo, Servier

Our periodic round-up of developments in the pharmaceutical manufacturing sector reveals a crop of facility news, with capital investments at …

New market access approach could save poorer countries millions

December 1, 2009
Sales and Marketing HIV, access, developing world

  An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …

Plan to bypass NICE put out for consultation

December 1, 2009
Sales and Marketing ABPI, Drayson, NICE

  The UK government is seeking industry input on its proposed pilot scheme to improve patient access to innovative drugs …

EU should require all trials to be registered, says IQWiG

December 1, 2009
Sales and Marketing Germany, IQWIG, health economics, hta

 Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …

ExonHit-Therapeutics-Herve100

Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics

December 1, 2009
Research and Development ExonHit Therapeutics, appointment, research and development

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …

Allston Landing

Genzyme hit by another contamination issue

November 30, 2009
Manufacturing and Production Cerezyme, Contamination, Genzyme

 Another manufacturing contamination issue has beset Genzyme, just as it seemed to be overcoming the problems at its Allston Landing …

Manufacturing news in brief

November 30, 2009
Manufacturing and Production Abraxis, DSM, Hovione, Lonza

Pharmafocus’ round-up of developments in the pharmaceutical manufacturing sector includes new contracts for CMOs Lonza and DSM, facility news for …

Burnham

New patient rights on the horizon

November 30, 2009
Medical Communications NHS, patient rights

The government’s much-vaunted improvements in hospital waiting times could have a basis in law as early as next April.Under new …

The Gateway to Local Adoption Series

Latest content